Clinical Trial Update: Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP) [Phase 2, Phase 3]

View source ↗

Summary

Open-label study of asfotase alfa in infants and children ≤5 years with hypophosphatasia completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatasia

Drugs mentioned

• Asfotase alfa (asfotase alfa)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hypophosphatasia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-02-26